Lisata Therapeutics Inc logo

Lisata Therapeutics Inc

$ 3.63 +0.01 (+0.28%) 10:08 PM EST
P/E:
At Loss
P/B:
0.40
Market Cap:
$ 28.53M
Enterprise V:
$ -46.45M
Volume:
332.00
Avg Vol (2M):
20.47K
Also Trade In:
Volume:
332.00
Market Cap $:
28.53M
PE Ratio:
At Loss
Avg Vol (2-Month):
20.47K
Enterprise Value $:
-46.45M
PB Ratio:
0.40
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 137.83
Equity-to-Asset 0.92
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -5.28
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 26.96
9-Day RSI 34.52
14-Day RSI 36.22
6-1 Month Momentum % -43.15
12-1 Month Momentum % -72.79

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.09
Quick Ratio 12.09
Cash Ratio 11.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -82.3

Financials (Next Earnings Date:2023-03-22 Est.)

LSTA's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LSTA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -12.32
Beta 0.96
Volatility % 43.16
14-Day RSI 36.22
14-Day ATR ($) 0.259277
20-Day SMA ($) 3.94266
12-1 Month Momentum % -72.79
52-Week Range ($) 3.5 - 17.099999
Shares Outstanding (Mil) 7.86

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lisata Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Lisata Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.